Is Wegovy Safe in Pregnancy? What the Guidance Actually Says

Wegovy has become one of the most talked-about medicines for weight management, and it is natural to wonder how it fits with pregnancy or trying to conceive. The short version from current sources is that Wegovy is not recommended in pregnancy, and its label advises stopping it a couple of months before a planned pregnancy. This is different from a medicine that treats an active, dangerous condition, but it still deserves a planned conversation with your clinician rather than a snap decision. This article gathers what leading U.S. sources say. It is general education only and is not a substitute for medical advice.

What Wegovy is and what it treats

Wegovy is a brand name for semaglutide, a medicine in the GLP-1 receptor agonist class. The same active ingredient is sold as Ozempic and Rybelsus for type 2 diabetes. GLP-1 medicines mimic a natural gut hormone that helps regulate blood sugar and appetite; Wegovy specifically is approved for chronic weight management, and it is usually given as a weekly injection. Because it works in part by reducing appetite and food intake, its whole purpose runs counter to what pregnancy needs, which is steady, adequate nutrition and appropriate weight gain.

What the guidance says about pregnancy use

The central message is straightforward. MotherToBaby, a service of the non-profit Organization of Teratology Information Specialists, notes that weight loss is not recommended during pregnancy and that the Wegovy label advises against use in pregnancy. So even setting aside questions about direct fetal risk, the medicine’s goal, weight loss, is not a pregnancy goal. For that reason alone, semaglutide is generally stopped when pregnancy is planned or discovered.

On direct fetal risk, human data are still limited, which is itself part of the reason for caution. MotherToBaby reports that in a study of 168 pregnant people who used GLP-1 medicines, including 51 who took semaglutide, no increased chance of birth defects was reported. That is somewhat reassuring, but the numbers are small, and limited data is not the same as proven safety. Animal studies have raised some concerns, and researchers note it can be hard to separate effects of the drug from effects of weight loss itself. The honest summary is that we do not yet have enough human evidence to call it safe, which is why the label and clinicians steer away from its use in pregnancy.

Why stopping before pregnancy matters, and the clearance window

Semaglutide leaves the body slowly. MotherToBaby notes that product labels for semaglutide products recommend stopping the medication about 2 months before getting pregnant, and that in healthy non-pregnant adults it can take up to about 6 weeks on average for most of the drug to clear. That long tail is the reason for the two-month buffer: it aims to have the medicine largely gone before conception. If pregnancy is on your horizon, this is worth planning in advance with your prescriber so the timing works out.

If you become pregnant while taking Wegovy

People do sometimes conceive unexpectedly while on semaglutide, and that is not a cause for panic or shame. The practical step is to contact your prescriber promptly to review your medicines and plan next steps; in most cases semaglutide would be stopped. The reassurance from the limited data available so far, including the study above, is a reasonable thing to hold onto while you talk with your clinician. MotherToBaby can also answer questions about your specific exposure, and can help put the current evidence in context.

The other side: don’t stop essential medicines on your own

It is important to separate Wegovy itself from any other medicines you may take. If semaglutide is being used purely for weight management, stopping it in pregnancy is generally appropriate and is what the label advises. But if you also manage diabetes or another condition, do not stop or change those treatments on your own. Untreated diabetes and obesity carry real pregnancy risks of their own, including higher chances of miscarriage, birth defects, and complications, so the goal is to move to a pregnancy-appropriate plan with your care team, not to go untreated. Your clinician can help you transition blood-sugar management to options used in pregnancy, such as other medicines where appropriate.

Breastfeeding

Data during breastfeeding are also limited. MotherToBaby notes that a small study did not detect semaglutide in breast milk at the doses studied, which is somewhat reassuring, while some product labeling still advises against use while breastfeeding because information is insufficient. Because the picture is incomplete, this is a decision to make with your clinician for your specific situation, and MotherToBaby can help you weigh what is known.

A note on the old letter categories

Older references sometimes assigned medicines an FDA pregnancy “category” letter. That system has been retired. U.S. drug labels now use a narrative format under the Pregnancy and Lactation Labeling Rule that describes what is actually known, which for newer medicines like semaglutide reflects the limited data honestly. Rely on current guidance rather than any old letter grade.

When to call your OB or prescriber

Reach out to your prescriber if you are taking Wegovy and are planning pregnancy, so you can time stopping it appropriately, and promptly if you discover you are pregnant while taking it. Contact your OB early in pregnancy to review all of your medicines and, if relevant, to plan diabetes management suited to pregnancy. For questions about a specific exposure, call MotherToBaby at 1-866-626-6847, a free service that answers questions about medicines in pregnancy and breastfeeding.

Frequently asked questions

Is Wegovy safe to take while pregnant? It is not recommended in pregnancy; the label advises against use, and weight loss is not a goal in pregnancy. Human data are limited, so semaglutide is generally stopped when pregnancy is planned or discovered.

How long before trying to conceive should I stop Wegovy? Product labels recommend stopping about 2 months before a planned pregnancy, largely because semaglutide clears slowly, taking up to about 6 weeks on average to mostly leave the body. Plan the timing with your prescriber.

I got pregnant while taking Wegovy. Should I worry? Try not to panic. Contact your prescriber promptly; semaglutide would usually be stopped. A study of people who used GLP-1 medicines early in pregnancy reported no increased chance of birth defects, though the data are still limited. MotherToBaby can help with your specific exposure.

Can I use Wegovy for weight loss during pregnancy? No. Weight loss is not recommended during pregnancy, and the Wegovy label advises against use. Pregnancy calls for adequate nutrition and appropriate weight gain, guided by your OB.

What about my diabetes medicine? If you manage diabetes, do not stop treatment on your own. Untreated diabetes carries its own pregnancy risks. Your clinician can move you to blood-sugar management suited to pregnancy, such as insulin where appropriate.

Can I take Wegovy while breastfeeding? The data are limited. A small study did not detect semaglutide in breast milk at the doses studied, but some labeling advises against use while breastfeeding due to insufficient information. Decide with your clinician for your situation.

Sources

• MotherToBaby (Organization of Teratology Information Specialists) — Semaglutide fact sheet and “Weighing In: How GLP-1s Fit into Your Pregnancy Plans.”
• Peer-reviewed literature indexed on NCBI / PubMed Central on periconceptional GLP-1 receptor agonist exposure and first-trimester semaglutide pregnancy outcomes.